HK Stock MarketDetailed Quotes

SCIENTECH (02291)

Watchlist
  • 11.070
  • -0.130-1.16%
Trading May 6 15:36 CST
3.84BMarket Cap14.47P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SCIENTECH (02291) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
Turnover
11.94%527.94M
32.36%329.71M
44.40%471.64M
49.74%249.1M
31.88%326.62M
33.29%166.35M
11.27%247.67M
12.47%124.8M
50.14%222.58M
52.68%169.15M
Operating income
11.94%527.94M
32.36%329.71M
44.40%471.64M
49.74%249.1M
31.88%326.62M
33.29%166.35M
11.27%247.67M
12.47%124.8M
50.14%222.58M
52.68%169.15M
Cost of sales
----
----
----
----
----
----
-11.77%-27.98M
-28.93%-15.32M
-65.44%-25.04M
-83.51%-19.39M
Operating expenses
-70.10%-80.99M
-102.22%-45.36M
-26.87%-47.61M
-20.48%-22.43M
-34.12%-37.53M
-21.51%-18.62M
-11.77%-27.98M
-28.93%-15.32M
-65.44%-25.04M
-83.51%-19.39M
Gross profit
5.41%446.95M
25.45%284.35M
46.68%424.03M
53.43%226.67M
31.59%289.09M
34.94%147.73M
11.21%219.69M
10.49%109.48M
48.40%197.55M
49.43%149.77M
Selling expenses
-50.19%-106.83M
-37.37%-43.25M
-56.76%-71.13M
-58.29%-31.49M
-17.36%-45.37M
-19.64%-19.89M
10.24%-38.66M
4.35%-16.63M
-86.09%-43.07M
-94.29%-28.4M
Administrative expenses
21.21%-28.08M
20.68%-14.61M
15.39%-35.64M
10.98%-18.41M
21.53%-42.13M
-26.10%-20.68M
10.34%-53.69M
32.94%-16.4M
-614.23%-59.87M
-585.29%-40.99M
Research and development expenses
-0.27%-58.15M
-16.99%-25.35M
6.58%-57.99M
21.35%-21.67M
-15.22%-62.07M
-40.32%-27.55M
-30.17%-53.87M
-19.40%-19.64M
-6.24%-41.39M
-2.04%-28.26M
Profit from asset sales
----
----
--32.65K
----
----
----
----
----
----
----
Revaluation surplus
----
----
----
295.62%1.6M
----
--404.88K
----
----
----
----
-Changes in the fair value of other assets
----
----
----
295.62%1.6M
----
--404.88K
----
----
----
----
Impairment and provision
66.97%-2.3M
65.97%-2.43M
-216.64%-6.98M
-2,618.22%-7.13M
204.44%5.98M
93.71%-262.19K
-1,174.48%-5.73M
-998.49%-4.17M
-20.68%533K
1,217.24%764K
-Other impairment is provision
66.97%-2.3M
65.97%-2.43M
-216.64%-6.98M
-2,618.22%-7.13M
204.44%5.98M
93.71%-262.19K
-1,174.48%-5.73M
-998.49%-4.17M
-20.68%533K
1,217.24%764K
Special items of operating profit
10.06%17.04M
116.05%6.5M
-32.31%15.48M
-47.34%3.01M
132.92%22.87M
131.25%5.72M
-406.79%-69.46M
-515.56%-18.29M
71.04%22.64M
-24.35%7.06M
Operating profit
-0.08%261.97M
34.15%200.9M
60.23%262.19M
80.43%149.76M
9,580.24%163.63M
141.58%83M
-102.26%-1.73M
-24.76%34.36M
-0.20%76.39M
-2.25%59.94M
Financing income
-17.66%18.32M
-28.45%9.5M
50.15%22.25M
128.26%13.28M
161.54%14.82M
253.63%5.82M
378.06%5.67M
644.34%1.65M
695.30%1.19M
700.00%880K
Financing cost
29.16%-116.64K
13.16%-74.17K
-13.96%-164.64K
10.40%-85.41K
99.24%-144.48K
99.11%-95.33K
-64.32%-18.97M
-1,070.46%-10.7M
-164,828.57%-11.55M
-124,240.00%-6.22M
Special items of earning before tax
-74.96%-77.35K
-102.26%-5.61K
-106.23%-44.21K
-80.98%248.36K
--709.59K
--1.31M
----
----
----
----
Earning before tax
-3.37%276.46M
28.41%210.77M
65.34%286.09M
88.43%164.14M
1,251.12%173.04M
244.22%87.11M
-122.77%-15.03M
-43.73%25.31M
-13.89%66.03M
-11.10%54.61M
Tax
----
----
----
----
----
----
34.77%-4.78M
67.19%-1.05M
7.30%-7.33M
54.16%-3.06M
After-tax profit from continuing operations
-2.37%239.73M
29.81%182.02M
62.22%245.56M
85.56%140.23M
864.04%151.38M
211.57%75.57M
-133.75%-19.81M
-41.93%24.26M
-14.65%58.7M
-5.86%51.55M
Earning after tax
-2.37%239.73M
29.81%182.02M
62.22%245.56M
85.56%140.23M
864.04%151.38M
211.57%75.57M
-133.75%-19.81M
-41.93%24.26M
-14.65%58.7M
-5.86%51.55M
Profit attributable to shareholders
-2.37%239.73M
29.81%182.02M
62.22%245.56M
85.56%140.23M
864.04%151.38M
211.57%75.57M
-133.75%-19.81M
-41.93%24.26M
-14.65%58.7M
-5.86%51.55M
Basic earnings per share
-2.82%0.69
29.80%0.5249
61.36%0.71
85.59%0.4044
833.33%0.44
211.29%0.2179
-131.58%-0.06
-53.33%0.07
-24.00%0.19
-15.00%0.17
Diluted earnings per share
-2.82%0.69
29.80%0.5249
61.36%0.71
85.59%0.4044
833.33%0.44
211.29%0.2179
-131.58%-0.06
-53.33%0.07
-24.00%0.19
-15.00%0.17
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Lixin Certified Public Accountants (Special General Partnership)
--
Lixin Certified Public Accountants (Special General Partnership)
--
PwC
--
PwC
--
PwC
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021
Turnover 11.94%527.94M32.36%329.71M44.40%471.64M49.74%249.1M31.88%326.62M33.29%166.35M11.27%247.67M12.47%124.8M50.14%222.58M52.68%169.15M
Operating income 11.94%527.94M32.36%329.71M44.40%471.64M49.74%249.1M31.88%326.62M33.29%166.35M11.27%247.67M12.47%124.8M50.14%222.58M52.68%169.15M
Cost of sales -------------------------11.77%-27.98M-28.93%-15.32M-65.44%-25.04M-83.51%-19.39M
Operating expenses -70.10%-80.99M-102.22%-45.36M-26.87%-47.61M-20.48%-22.43M-34.12%-37.53M-21.51%-18.62M-11.77%-27.98M-28.93%-15.32M-65.44%-25.04M-83.51%-19.39M
Gross profit 5.41%446.95M25.45%284.35M46.68%424.03M53.43%226.67M31.59%289.09M34.94%147.73M11.21%219.69M10.49%109.48M48.40%197.55M49.43%149.77M
Selling expenses -50.19%-106.83M-37.37%-43.25M-56.76%-71.13M-58.29%-31.49M-17.36%-45.37M-19.64%-19.89M10.24%-38.66M4.35%-16.63M-86.09%-43.07M-94.29%-28.4M
Administrative expenses 21.21%-28.08M20.68%-14.61M15.39%-35.64M10.98%-18.41M21.53%-42.13M-26.10%-20.68M10.34%-53.69M32.94%-16.4M-614.23%-59.87M-585.29%-40.99M
Research and development expenses -0.27%-58.15M-16.99%-25.35M6.58%-57.99M21.35%-21.67M-15.22%-62.07M-40.32%-27.55M-30.17%-53.87M-19.40%-19.64M-6.24%-41.39M-2.04%-28.26M
Profit from asset sales ----------32.65K----------------------------
Revaluation surplus ------------295.62%1.6M------404.88K----------------
-Changes in the fair value of other assets ------------295.62%1.6M------404.88K----------------
Impairment and provision 66.97%-2.3M65.97%-2.43M-216.64%-6.98M-2,618.22%-7.13M204.44%5.98M93.71%-262.19K-1,174.48%-5.73M-998.49%-4.17M-20.68%533K1,217.24%764K
-Other impairment is provision 66.97%-2.3M65.97%-2.43M-216.64%-6.98M-2,618.22%-7.13M204.44%5.98M93.71%-262.19K-1,174.48%-5.73M-998.49%-4.17M-20.68%533K1,217.24%764K
Special items of operating profit 10.06%17.04M116.05%6.5M-32.31%15.48M-47.34%3.01M132.92%22.87M131.25%5.72M-406.79%-69.46M-515.56%-18.29M71.04%22.64M-24.35%7.06M
Operating profit -0.08%261.97M34.15%200.9M60.23%262.19M80.43%149.76M9,580.24%163.63M141.58%83M-102.26%-1.73M-24.76%34.36M-0.20%76.39M-2.25%59.94M
Financing income -17.66%18.32M-28.45%9.5M50.15%22.25M128.26%13.28M161.54%14.82M253.63%5.82M378.06%5.67M644.34%1.65M695.30%1.19M700.00%880K
Financing cost 29.16%-116.64K13.16%-74.17K-13.96%-164.64K10.40%-85.41K99.24%-144.48K99.11%-95.33K-64.32%-18.97M-1,070.46%-10.7M-164,828.57%-11.55M-124,240.00%-6.22M
Special items of earning before tax -74.96%-77.35K-102.26%-5.61K-106.23%-44.21K-80.98%248.36K--709.59K--1.31M----------------
Earning before tax -3.37%276.46M28.41%210.77M65.34%286.09M88.43%164.14M1,251.12%173.04M244.22%87.11M-122.77%-15.03M-43.73%25.31M-13.89%66.03M-11.10%54.61M
Tax ------------------------34.77%-4.78M67.19%-1.05M7.30%-7.33M54.16%-3.06M
After-tax profit from continuing operations -2.37%239.73M29.81%182.02M62.22%245.56M85.56%140.23M864.04%151.38M211.57%75.57M-133.75%-19.81M-41.93%24.26M-14.65%58.7M-5.86%51.55M
Earning after tax -2.37%239.73M29.81%182.02M62.22%245.56M85.56%140.23M864.04%151.38M211.57%75.57M-133.75%-19.81M-41.93%24.26M-14.65%58.7M-5.86%51.55M
Profit attributable to shareholders -2.37%239.73M29.81%182.02M62.22%245.56M85.56%140.23M864.04%151.38M211.57%75.57M-133.75%-19.81M-41.93%24.26M-14.65%58.7M-5.86%51.55M
Basic earnings per share -2.82%0.6929.80%0.524961.36%0.7185.59%0.4044833.33%0.44211.29%0.2179-131.58%-0.06-53.33%0.07-24.00%0.19-15.00%0.17
Diluted earnings per share -2.82%0.6929.80%0.524961.36%0.7185.59%0.4044833.33%0.44211.29%0.2179-131.58%-0.06-53.33%0.07-24.00%0.19-15.00%0.17
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)IASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Lixin Certified Public Accountants (Special General Partnership)--Lixin Certified Public Accountants (Special General Partnership)--PwC--PwC--PwC--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.17%
Sample Name
Sample Code
 +4.80%
Sample Name
Sample Code
 +3.55%
4
KUNLUN ENERGY
00135
+3.31%
5
SINOPEC CORP
00386
+2.18%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +61.02%
Sample Name
Sample Code
 +51.07%
Sample Name
Sample Code
 +40.94%
4
Business-intelligence Of Oriental Nations Corporation
300166
+33.12%
5
Emdoor Information
001314
+32.98%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -